[
  {
    "phenotype_id": "PH3235",
    "phenotype_version_id": 8219,
    "name": "NHS England Low Priority Treatment - oxycodone and naloxone combination product",
    "definition": "This codelist was taken from [OpenCodelists](https://www.opencodelists.org/), created by [OpenSAFELY](https://www.opensafely.org/). We recommend viewing this Phenotype on the OpenCodelist website to view the most recent version.\n\n\nUsed by the following [OpenPrescribing](https://openprescribing.net) measures:\n\n\n- [NHS England Low Priority Treatment \\- oxycodone and naloxone combination product](https://openprescribing.net/measure/lpoxycodone/)\n\n\n© University of Oxford for the Bennett Institute for Applied Data Science 2025\\. This work may be copied freely for non\\-commercial research and study.\n\n",
    "implementation": null,
    "publications": null,
    "validation": null,
    "citation_requirements": null,
    "created": "2026-01-26T23:07:20.030823Z",
    "author": "OpenPrescribing",
    "collections": [
      {
        "name": "OpenCodelist",
        "value": 31
      },
      {
        "name": "Phenotype Library",
        "value": 18
      }
    ],
    "tags": null,
    "organisation": {
      "id": 1,
      "slug": "opensafely",
      "name": "OpenSAFELY"
    },
    "world_access": 1,
    "updated": "2026-01-26T23:07:20.026487Z",
    "references": [
      {
        "url": "https://openprescribing.net/measure/lpoxycodone/",
        "title": "OpenPrescribing measure: NHS England Low Priority Treatment - oxycodone and naloxone combination product"
      }
    ],
    "signed_off": [],
    "methodology": "",
    "coding_system": [
      {
        "name": "BNF codes",
        "value": 11
      }
    ],
    "open_codelist_id": "openprescribing/nhs-england-low-priority-treatment-oxycodone-and-naloxone-combination-product",
    "source_reference": "https://www.opencodelists.org/codelist/openprescribing/nhs-england-low-priority-treatment-oxycodone-and-naloxone-combination-product/5d0906df",
    "concept_information": [
      {
        "concept_id": 8396,
        "concept_version_id": 15881,
        "concept_name": "openprescribing/nhs-england-low-priority-treatment-oxycodone-and-naloxone-combination-product/5d0906df",
        "coding_system": {
          "id": 11,
          "name": "BNF codes",
          "description": "BNF codes"
        },
        "phenotype_id": "PH3235",
        "phenotype_version_id": 8219,
        "phenotype_name": "NHS England Low Priority Treatment - oxycodone and naloxone combination product",
        "code_attribute_header": [],
        "codes": [
          {
            "code": "0407020AFAAAAAA",
            "description": "Oxycodone 10mg / Naloxone 5mg modified-release tablets",
            "attributes": null
          },
          {
            "code": "0407020AFAAABAB",
            "description": "Oxycodone 20mg / Naloxone 10mg modified-release tablets",
            "attributes": null
          },
          {
            "code": "0407020AFAAACAC",
            "description": "Oxycodone 5mg / Naloxone 2.5mg modified-release tablets",
            "attributes": null
          },
          {
            "code": "0407020AFAAADAD",
            "description": "Oxycodone 40mg / Naloxone 20mg modified-release tablets",
            "attributes": null
          },
          {
            "code": "0407020AFAAAEAE",
            "description": "Oxycodone 40mg/5ml / Naloxone 20mg/5ml oral suspension",
            "attributes": null
          },
          {
            "code": "0407020AFBBAAAA",
            "description": "Targinact 10mg/5mg modified-release tablets",
            "attributes": null
          },
          {
            "code": "0407020AFBBABAB",
            "description": "Targinact 20mg/10mg modified-release tablets",
            "attributes": null
          },
          {
            "code": "0407020AFBBACAC",
            "description": "Targinact 5mg/2.5mg modified-release tablets",
            "attributes": null
          },
          {
            "code": "0407020AFBBADAD",
            "description": "Targinact 40mg/20mg modified-release tablets",
            "attributes": null
          }
        ]
      }
    ],
    "coding_system_release": "",
    "open_codelist_version_id": "5d0906df",
    "open_codelist_version_tag": "",
    "status": 1,
    "doi": "https://doi.org/10.48533/4yct-9k44",
    "is_deleted": false,
    "publish_status": 2,
    "owner": "ieuan.scanlon",
    "template": {
      "id": 3,
      "name": "OpenCodelists Phenotype",
      "description": "OpenSafely's OpenCodelist Phenotype, visit https://www.opencodelists.org/ to learn more",
      "version_id": 1
    },
    "versions": [
      {
        "version_id": 8219,
        "version_name": "NHS England Low Priority Treatment - oxycodone and naloxone combination product",
        "version_date": "2026-01-26T23:07:20.037196Z",
        "is_published": true,
        "is_latest": true
      }
    ]
  }
]